MNC Kapital Indonesia Tbk vs Tempo Scan Pacific Tbk. — how do they compare? MNC Kapital Indonesia Tbk trades at Rp50 (market cap 2.13T, 136K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,500 (market cap 11.36T, 200K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 5.3× MNC Kapital Indonesia Tbk's market cap, and Tempo Scan Pacific Tbk. is more actively traded (200K versus 136K). Which is the better fit depends on your goals.
| BCAP | TSPC | |
|---|---|---|
Market Cap | 2.13T | 11.36T |
Volume | 136K | 200K |
Lot | 1.36K | 2K |
Turnover | 6.8M | 500.06M |
Average Price | 50 | 2,500.28 |
Value | 6.8M | 500.06M |
Indicative Equilibrium Price | 50 | 2,500 |
Indicative Equilibrium Volume | 1 | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT MNC Kapital Indonesia Tbk formerly PT Bhakti Capital Indonesia Tbk was established on 15 July 1999, resulting from the restructuring and consolidation of PT Bhakti Investama Tbk, its holding company. At the time it was established, the Company commenced its business activities in the securities sector, among others are financial advisory, brokerage, underwriting, and research and development. In 2003, the Company carried out a business consolidation and transformed into a holding company of several subsidiaries that are engaged in financial services sector, namely PT Bhakti Finance, PT Bhakti Securities, and PT Bhakti Asset Management.
Read more on BCAP →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →